Regulation 7 The Controlled Drugs (Supervision of Management and Use) (Wales) Regulations 2008I1

England and Wales

(1)

The Controlled Drugs (Supervision of Management and Use) (Wales) Regulations 2008 M1 are amended as follows.

(2)

In regulation 2(1) (interpretation)—

(a)

omit the definition of “the GDPR”;

(b)

at the appropriate place insert—

““the UK GDPR” (“GDPR y DU”) has the same meaning as in Parts 5 to 7 of the Data Protection Act 2018 (see section 3(10) and (14) of that Act);”.

(3)

In regulation 25(7) (duty to co-operate by disclosing information as regards relevant persons), for “GDPR” substitute “ UK GDPR ”.

(4)

In regulation 26(6) (responsible bodies requesting additional information be disclosed about relevant persons), for “GDPR” substitute “ UK GDPR ”.

(5)

In regulation 29(3) (occurrence reports), for “GDPR” substitute “ UK GDPR ”.

Annotations

M1: S.I. 2008/3239 (W. 286), amended by section 211(1)(b) of, and paragraph 334 of Schedule 19 to, the Data Protection Act 2018 (c. 12). Relevant amendments are made by S.I. 2019/419 but these do not come into force until exit day. There are other amending instruments but none is relevant.

I1: Reg. 7 in force on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)